Boston Scientific (BSX) shares are getting a boost today after the company said it has tapped a Johnson & Johnson (JNJ) exec as next-in-line for its CEO job. Michael Mahoney, chairman of the medical device and diagnostics group at J&J, will become president of Boston Scientific as of October 17.
